Henan Tongwei Medical Equipment Co., LtdCall us : +86 − −19139704654 // Email us : [email protected]

MENU China Mining Equipment Industry & Technology Group Co., Ltd.
  • Home
  • Products
  • About
  • Contact

Home / Products

identification of the molecular basis of doxorubicin

  • Cellular and Molecular Biology

    The mechanistic basis for the biological properties of Morus alba flavonoid extract (MFE) and chemotherapy drug of doxorubicin on human colon cancer HT-29 cell line death are unknown The effect of doxorubicin and flavonoid extract on colon cancer HT-29 cell line death and identification of gene expression and PARP concentration of HT-29

    Get Price
  • Cardioprotective effects of curcumin and nebivolol against

    Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats Show all authors S The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity Bawa-Khalfe T Identification of the molecular basis of doxorubicin-induced cardiotoxicity

    Get Price
  • Cancers

    However the molecular basis of the protective role of melatonin and the impact on doxorubicin response of breast cancer cells still largely remain to be elucidated This prompted us to perform a thorough analysis to decipher the functional role of melatonin on doxorubicin-treated breast cancer cells and to identify the molecular mechanisms and

    Get Price
  • Effects of the chemotherapeutic agent doxorubicin on the

    Figure 1 EPCR cell surface total protein and mRNA levels in doxorubicin-treated HUVECs A cell surface levels of EPCR in doxorubicin (dox)–treated HUVECs were determined by flow cytometry using FITC-conjugated anti-EPCR (JRK 1535) monoclonal antibody B Western blot analysis of whole-cell EPCR levels in doxorubicin-treated HUVECs Lane 1 molecular

    Get Price
  • Mitochondrial Determinants of Doxorubicin

    Interference with different mitochondrial processes is chief among the molecular and cellular determinants of doxorubicin cardiotoxicity contributing to the development of cardiomyopathy The present review provides the basis for the involvement of mitochondrial toxicity in the different functional hallmarks of anthracycline toxicity

    Get Price
  • Identification Of A Molecular Basis For The Juvenile

    Sleep is a highly conserved behavior critical to nervous system function Across species sleep amounts are highest in young animals and taper with maturity These ontogenetic changes to sleep have long been thought to facilitate brain maturation Indeed developmental sleep abnormalities are highly prevalent across neuropsychiatric disorders However knowledge of the genetic and molecular

    Get Price
  • Pharmacodynamics of doxorubicin in human bladder tumors

    Intravesical doxorubicin treatment delivers high drug concentrations to the bladder wall yet the treatment produces only a variable and incomplete response in superficial bladder cancer and insignificant activity in muscle-invading disease This study evaluated the pharmacological basis for the clinical observations and potential prognostic indicators of tumor sensitivity to doxorubicin

    Get Price
  • Bioinformatics identification of potential candidate blood

    The underlying molecular mechanism of doxorubicin-induced HF is not completely consistent with non-pharmaceutical HF Some potential more important indicators specified for doxorubicin-induced HF may be concealed by the validation with the study GSE9128 designed for the identification

    Get Price
  • Cancers

    However the molecular basis of the protective role of melatonin and the impact on doxorubicin response of breast cancer cells still largely remain to be elucidated This prompted us to perform a thorough analysis to decipher the functional role of melatonin on doxorubicin-treated breast cancer cells and to identify the molecular

    Get Price
  • Study Uncovers Link Between Chemotherapy Drug and Heart

    Nov 02 2012A team of scientists at the University of Texas MD Anderson Cancer Center have solved a longstanding mystery about doxorubicin's role in the destruction of heart tissue a finding that will help identify the patients who can safely tolerate the drug "Even in this age of targeted therapies doxorubicin

    Get Price
  • Doxorubicin

    Thus Top2a is thought to be the molecular basis of doxorubicin's anti-tumor activity On the other hand doxorubicin is believed to cause dose-dependent cardiotoxicity through redox-cycling and generation of reactive oxygen species (ROS) Recently we showed that cardiomyocyte-specific deletion of Top2b protected cardiomyocytes from

    Get Price
  • Identification of the molecular basis of doxorubicin

    title = Identification of the molecular basis of doxorubicin-induced cardiotoxicity abstract = Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS)

    Get Price
  • Pathways of cardiac toxicity: comparison between

    Jun 25 2016Zhang S Liu X Bawa-Khalfe T Lu L-S Lyu YL Liu LF Yeh ETH (2012) Identification of the molecular basis of doxorubicin-induced cardiotoxicity Nat Med 18(11):1639–1642 doi:10 1038/nm 2919 CAS Article PubMed Google Scholar

    Get Price
  • Microarray

    Breast cancer is a disease that is diverse in natural history response to treatment and patient outcomes It remains the most common non-cutaneous malignancy with an estimated 192 370 new cases in 2009 in the United States 1 Breast cancer-associated mortality is second only to lung cancer in the United States with an estimated 40 170 deaths in 2009 1 Breast cancer is also the most

    Get Price
  • Molecular Mechanism of Chemoresistance by Astrocyte

    In the present study we elucidate a molecular mechanism of AEG-1–induced chemoresistance an important characteristic of aggressive cancers AEG-1 increases the expression of multidrug resistance gene 1 (MDR1) protein resulting in increased efflux and decreased accumulation of doxorubicin promoting doxorubicin resistance

    Get Price
  • Doxorubicin induces cardiotoxicity through upregulation of

    Doxorubicin is a highly effective anticancer agent but causes cardiotoxicity in many patients The mechanisms of doxorubicin-induced cardiotoxicity remain incompletely understood Here we investigated doxorubicin-induced cytotoxicity in human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs) We found that doxorubicin

    Get Price
  • Separate and Combined Effects of DNMT and HDAC Inhibitors

    Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research A phenomenon which is common to both intrinsic and acquired resistance is the aberrant alteration of gene expression in drug-resistant cancers

    Get Price
  • Sequential Dose

    In an effort to reduce this limitation the incorporation of gene expression analyses has permitted the improvement in diagnosis prognosis prediction [23–25] and the identification of new molecular targets that may be used for the development of new drugs The new era of molecular

    Get Price
  • Identification of Genes Required for Protection from

    Identification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiae The basis for the antineoplastic effectiveness of anthracyclines (e g The identification of such a network of 40 genes strongly suggests the potential molecular pathways that confer doxorubicin

    Get Price
  • Identification of the molecular basis of doxorubicin

    Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS) Here we show that cardiomyocyte-specific deletion of Top2b (encoding topoisomerase-IIβ) protects cardiomyocytes from doxorubicin-induced DNA double-strand breaks and transcriptome changes that are responsible for defective mitochondrial biogenesis

    Get Price
  • Doxorubicin Hydrochloride Liposome

    Doxorubicin hydrochloride liposome is a form of doxorubicin hydrochloride contained inside liposomes (very tiny particles of fat) This form may work better than other forms of doxorubicin hydrochloride and have fewer side effects Also because its effects last longer

    Get Price
  • Drug: Doxorubicin

    The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics Massachusetts General Hospital Cancer Center (USA) This work is funded by Wellcome

    Get Price
  • Molecular Mechanism of Chemoresistance by Astrocyte

    In the present study we elucidate a molecular mechanism of AEG-1–induced chemoresistance an important characteristic of aggressive cancers AEG-1 increases the expression of multidrug resistance gene 1 (MDR1) protein resulting in increased efflux and decreased accumulation of doxorubicin promoting doxorubicin

    Get Price
  • Molecular Basis of Doxorubicin

    Molecular Basis of Doxorubicin-induced Cardiotoxicity Cardiology Grand Rounds Date: 2/27/13 1pm to 2pm Time: 2/27/13 1pm to 2pm Location: FCT3 5001 Format: Grand Rounds CME: 1 Hr Category 1 Speaker: Edward T H Yeh MD Speaker Bio: Professor and Chairman Department of Cardiology Division of Internal Medicine The University of Texas MD Anderson Cancer Center Houston TX

    Get Price
  • A small molecule inhibitor of PAI

    N2 - Doxorubicin an anthracycline antibiotic is a commonly used anticancer drug In spite of its widespread usage its therapeutic effect is limited by its cardiotoxicity On the cellular level Doxorubicin-induced cardiotoxicity manifests as stress induced premature senescence

    Get Price
  • A Prognostic Gene Expression Signature in the Molecular

    A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-nave Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate Vinblastine Doxorubicin

    Get Price
  • Molecular basis of bortezomib resistance: proteasome

    To explore the molecular basis of acquired resistance to bor-tezomib human monocytic/macrophage THP1 cells were exposed in vitro over a period of 6 months to stepwise increasing concentrations of bortezomib representing approximately 1- to 50-fold the IC 50 (2 5 nM to 200 nM)

    Get Price
  • Supplementary Information Nature Medicine Identification

    Identification of the Molecular Basis of Doxorubicin-induced Cardiotoxicity Corresponding author: Edward T H Yeh Contents: Supplementary Figure 1a Top2b expression in the hearts by immunofluorescence Supplementary Figure 1b Top2b expression in the hearts by Western blot Supplementary Figure 2a Phospho-p53 expression in the hearts

    Get Price
  • Doxil

    Aug 01 2019In contrast to doxorubicin which displays a large volume of distribution (range 700 to 1100 L/m 2) the small steady state volume of distribution of liposomal doxorubicin suggests that Doxil is largely confined to vascular fluid Doxorubicin becomes available after the liposomes are extravasated

    Get Price
  • Frontline rituximab cyclophosphamide doxorubicin and

    Treatment comprised rituximab 375 mg/m 2 cyclophosphamide 750 mg/m 2 doxorubicin 50 mg/m 2 all IV on day 1 and prednisone 100 mg/m 2 orally (PO) on days 1 to 5 plus either bortezomib 1 3 mg/m 2 IV on days 1 4 8 11 (VR-CAP) of each cycle or vincristine

    Get Price
  • Determining the genetic basis of anthracycline

    Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy regimes with almost half of patients expected to develop congestive heart failure given high doses However the genetic basis of sensitivity to anthracyclines remains unclear We created a panel of iPSC-derived cardiomyocytes from 45 individuals and performed RNA-seq after 24 hr exposure to

    Get Price
  • facemask usa made

    fashion brands making cloth masks you can buy now

    china best selling disposable nonwoven children face

    disposable gowns 鈥 personal protection equipment

    china high quality 3 plys kn95 n95 disposable

    asus control center

    the risks of social isolation

    2 paar in bh cups soft schaum bh enhancers badeanzug

    earthadelic outdoor structures

    vente vhicules utilitaires

    medical isolation gowns

    superior disposable flu medical mask for home use in

    us military surplus chimique costume battle dress

    factory disposable surgical nonwoven overshoes with elastic

    china disposable chemical protective coverall and

    fashion brands that donate to charity during coronavirus

    china disposable industrial protective n95 face mask

    medical isolation gown from china manufacturer

    china custom printing high quality vintage metal tin

    pipe coiler winder machine

    introduction to github

    china plastic pp pe pipe extrusion line

    the national haemodialysis quality standards 2020

    paid sick safe time laws and covid-19

    china nonwoven filtration materials of medical mask

    yellow 鈥 precept 鈥 medical products

    1600mm meltblown nonwoven fabric extrusion machine

    bei facebook anmelden

Henan Tongwei

Henan Tongwei Medical Device Co., Ltd. is a branch company of Guangzhou Ningwei Technology Co., LTD., which is specialized in the production, processing, sales, research and development and service of related products and equipment in the medical device industry.

Contact Us

  • : Room 810, Block B, Jinzhonghuan Building, Zhengzhou City, Henan Province
  • : +86 19139704654
  • : [email protected]

products

NIOSH N95

Mask Machine

hospital doctor safety ppe coverall medical protection suit with hood

BFE99 Melt Blown Fabric

surgical gown aami level 3

7/24 | Online | Chat | Now TONGWEIMEDICAL © All Rights Reserved.